NU 553 ADVANCED PHARMACOLOGY AND PHARMACOTHERAPEUTICS EXAM –
QUESTIONS AND ANSWERS | VERIFIED AND WELL DETAILED ANSWERS | PLUS
RATIONALES | GUARANTEED PASS | LATEST EXAM UPDATE
CORE DOMAINS*
• Pharmacokinetics
• Pharmacodynamics
• Cardiovascular Pharmacotherapy
• Endocrine Pharmacology
• Anti-Infective Therapy
• Pain Management and Controlled Substances
• Neuropharmacology and Psychiatric Medications
• Drug Safety, Adverse Reactions, and Monitoring
• Prescriptive Authority, Legal, and Ethical Standards
• Evidence-Based Pharmacotherapeutic Decision-Making
INTRODUCTION*
This examination evaluates advanced knowledge and clinical application of pharmacology
and pharmacotherapeutics across diverse patient populations. The assessment measures
competency in pharmacokinetics, pharmacodynamics, medication selection, monitoring,
,adverse effect management, and evidence-based prescribing. Questions include both
traditional multiple-choice and scenario-based clinical applications designed to assess
critical thinking and therapeutic decision-making. Emphasis is placed on safe prescribing
practices, patient-centered care, legal and ethical responsibilities, and real-world
management of acute and chronic conditions. Candidates are expected to integrate scientific
principles with clinical judgment to optimize therapeutic outcomes while minimizing
medication-related risks.
SECTION ONE (QUESTIONS 1–50)
1. Which pharmacokinetic process describes the movement of a drug from the
bloodstream into body tissues?
A. Metabolism
B. Distribution
C. Excretion
D. Absorption
🟢 Correct Answer: B. Distribution
🔴 Explanation: Distribution refers to the movement of a drug from systemic circulation
into tissues and body fluids.
,2. A patient taking warfarin is prescribed trimethoprim-sulfamethoxazole.
What is the primary concern?
A. Reduced anticoagulation
B. Increased INR and bleeding risk
C. Hypertension
D. Bradycardia
🟢 Correct Answer: B. Increased INR and bleeding risk
🔴 Explanation: Trimethoprim-sulfamethoxazole inhibits warfarin metabolism and can
significantly increase bleeding risk.
3. Which receptor activation is primarily responsible for bronchodilation?
A. Alpha-1
B. Muscarinic M3
C. Beta-2
D. Dopamine D2
🟢 Correct Answer: C. Beta-2
🔴 Explanation: Beta-2 receptor stimulation relaxes bronchial smooth muscle, producing
bronchodilation.
, 4. A medication with high first-pass metabolism is most affected by which
organ?
A. Kidney
B. Lung
C. Liver
D. Spleen
🟢 Correct Answer: C. Liver
🔴 Explanation: First-pass metabolism occurs primarily in the liver before a drug reaches
systemic circulation.
5. Which antihypertensive is contraindicated during pregnancy?
A. Methyldopa
B. Labetalol
C. Nifedipine
D. Lisinopril
🟢 Correct Answer: D. Lisinopril
🔴 Explanation: ACE inhibitors are teratogenic and should be avoided during pregnancy.
QUESTIONS AND ANSWERS | VERIFIED AND WELL DETAILED ANSWERS | PLUS
RATIONALES | GUARANTEED PASS | LATEST EXAM UPDATE
CORE DOMAINS*
• Pharmacokinetics
• Pharmacodynamics
• Cardiovascular Pharmacotherapy
• Endocrine Pharmacology
• Anti-Infective Therapy
• Pain Management and Controlled Substances
• Neuropharmacology and Psychiatric Medications
• Drug Safety, Adverse Reactions, and Monitoring
• Prescriptive Authority, Legal, and Ethical Standards
• Evidence-Based Pharmacotherapeutic Decision-Making
INTRODUCTION*
This examination evaluates advanced knowledge and clinical application of pharmacology
and pharmacotherapeutics across diverse patient populations. The assessment measures
competency in pharmacokinetics, pharmacodynamics, medication selection, monitoring,
,adverse effect management, and evidence-based prescribing. Questions include both
traditional multiple-choice and scenario-based clinical applications designed to assess
critical thinking and therapeutic decision-making. Emphasis is placed on safe prescribing
practices, patient-centered care, legal and ethical responsibilities, and real-world
management of acute and chronic conditions. Candidates are expected to integrate scientific
principles with clinical judgment to optimize therapeutic outcomes while minimizing
medication-related risks.
SECTION ONE (QUESTIONS 1–50)
1. Which pharmacokinetic process describes the movement of a drug from the
bloodstream into body tissues?
A. Metabolism
B. Distribution
C. Excretion
D. Absorption
🟢 Correct Answer: B. Distribution
🔴 Explanation: Distribution refers to the movement of a drug from systemic circulation
into tissues and body fluids.
,2. A patient taking warfarin is prescribed trimethoprim-sulfamethoxazole.
What is the primary concern?
A. Reduced anticoagulation
B. Increased INR and bleeding risk
C. Hypertension
D. Bradycardia
🟢 Correct Answer: B. Increased INR and bleeding risk
🔴 Explanation: Trimethoprim-sulfamethoxazole inhibits warfarin metabolism and can
significantly increase bleeding risk.
3. Which receptor activation is primarily responsible for bronchodilation?
A. Alpha-1
B. Muscarinic M3
C. Beta-2
D. Dopamine D2
🟢 Correct Answer: C. Beta-2
🔴 Explanation: Beta-2 receptor stimulation relaxes bronchial smooth muscle, producing
bronchodilation.
, 4. A medication with high first-pass metabolism is most affected by which
organ?
A. Kidney
B. Lung
C. Liver
D. Spleen
🟢 Correct Answer: C. Liver
🔴 Explanation: First-pass metabolism occurs primarily in the liver before a drug reaches
systemic circulation.
5. Which antihypertensive is contraindicated during pregnancy?
A. Methyldopa
B. Labetalol
C. Nifedipine
D. Lisinopril
🟢 Correct Answer: D. Lisinopril
🔴 Explanation: ACE inhibitors are teratogenic and should be avoided during pregnancy.
